Modeling clinical efficacy of the S1P receptor modulator ponesimod in psoriasis

Psoriasis is a chronic inflammatory disorder with substantial impact on quality of life [1,2]. The most common form is plaque psoriasis. The disease is mediated by T cells [3] and manifests itself as inflammation of the skin with plaque formation and rapid growth of skin cells [4,5].